HereToStudy
Primordial Performance -
Ology members,
The 3rd generation of AndroLean is here -- AndroLean v3
Building a lean, muscular physique is virtually impossible without sufficient androgen levels. AndroLean v3 delivers the strongest legal androgens found in the human body -- which pushes blood levels past the ***8220;androgen threshold***8221; for leaner, denser muscles.
Our first AndroLean v3 tester, Tomas P, lost 5% body fat and gained 6lbs of lean mass in only 8 weeks -- with nearly zero side-effects. See the progress pictures here -
Tomas P. - AndroLean - download case report
How is AndroLean so effective?
***8226; Highly Dosed - Contains the highest dose of androgens found in any natural androgen product
***8226; Highly Anabolic -Super 11-DHEA & Super 7-DHEA is highly anabolic and minimally androgenic for more muscle and less side effects.
***8226; Highly Absorbable - Bypasses the liver and increases blood androgen levels for nearly 24hrs
What are the active ingredients?
The androgens in AndroLean include -
Super-11-DHEA & Super-7-DHEA - These natural 'oxygenated' androgens inhibit 11b-HSD1 by attaching to the 11b-HSD1 enzyme,
deactivating the conversion of cortisone into cortisol. These fat destroying androgens will fight stubborn belly fat while safely building quality muscle mass. (4-12)
Together, these androgens mimic the power of true injectable testosterone without the androgenic side effects -- with a bioequivalence of 300mg/week injectable testosterone enanthate -- so you can make serious gains without breaking the law. (39-50)
*From a baseline of 500ng/dl total androgen activity level.
AndroLean = More Permanent Gains
Results from AndroLean are generally higher quality compared to methylated oral steroids -- making the gains easier to maintain, and longer lasting.
Methylated compounds such as superdrol, epistane, halodrol, dimethazine, etc., cause a rapid uptake of ionic fluid in the first 3-5 days leading to the rapid onset of muscular pumps, strength and weight gain. However, this fluid retention is rapidly lost after the cycle and gains are difficult to keep. (1)
The best results from AndroLean are often seen after 3-4 weeks when the development of new myoblasts (muscle fibers) begin to take shape, and fat cells begin to shrink. (54-59) The development of muscle fibers and increased number of nuclei is a long-term benefit that is more easily maintained for many months or years. (54,55) Users of AndroLean report nearly 75% retention of gains, even 8 weeks after discontinuing their cycle. (39-50)
Even extreme reduction in body fat is a long-term benefit that stays long after discontinuation of AndroLean with continued diet and exercise.
The results from AndroLean are dramatic and noticeable when complemented with heavy lifting and a high protein diet.
AndroLean will produce noticeable effects quickly.
Effects after 1-2 weeks ***8211;
***8226; Tighter muscles
***8226; Increased endurance
***8226; Reduced bloat
... And then after 3-4 weeks ***8211;
***8226; 1-3lb lean mass increase
***8226; Increased muscle definition
***8226; Leaner mid-section
AndroLean = Less Side-Effects
AndroLean was painstakingly optimized to bring maximum results with minimal side-effects -- it***8217;s unlike anything on the market.
Side-effects from AndroLean are mild, temporary, and usually completely unnoticed by users. Some men may even notice improved general health while supplementing with AndroLean, since low androgen (testosterone) levels can lead to diabetes, obesity, heart disease, and depression. (60-62)
AndroLean = Easy Recovery
A rapid and complete recovery of natural testosterone production, ensures the maximum gain retention.
Users of methylated orals and injectable steroids often struggle from a prolonged recovery, due to the highly suppressive nature of these types of steroids. (35-36) Recovery from these compounds can take months, or even years. (35-38) This makes it extremely difficult to maintain gains, sex-life, and mental health.
AndroLean has one MAJOR advantage over the alternative -
24hr Release - Mimics the body***8217;s natural rhythm(LH & FSH secretion)
The single daily dose of AndroLean rises and falls within a 24 hour period. This ensures levels fall back to ***8220;pre-dose***8221; levels every 24 hours, allowing natural testosterone production to be stimulated. This prevents testicular shrinkage, shutdown and prolonged recovery. (63,64)
Since AndroLean contains only androgens naturally produced by the body, they are easily metabolized and cleared from the body -- This allows users of AndroLean to fully recover in 30 days or less.
AndroLean = Superior Delivery
AndroLean utilizes the new Liqua-Vade 24HR Delivery technology -
***8226; Highly Bioavailable- Fat soluble androgens absorb up to 98% and bypass the liver
***8226; Highly Reliable - Maximum absorption is not dependant on food intake
***8226; Highly Convenient - Only ONE daily dose required for 24hr timed release of androgens
We accomplished ultra-high bioavailability by utilizing fat soluble ***8220;fatty ester***8221; hormones which are absorbed by the ***8220;fat uptake***8221; (lymphatic) system, seen here -
AndroLean = Cost Effective
When priced against the nearest competition, AndroLean is at least 200-1000% more cost effective.
In fact, we encourage you to compare for yourself. Plus, consider the things you DON***8217;T need with AndroLean -
***8226; Liver, kidney, or blood pressure support
***8226; Little blue pills to keep "things working"
***8226; Harsh "research grade" post cycle therapy (pct) drugs
***8226; Needles & sterilization
Primordial Performance = The #1 Source for Androgens
Primordial Performance is the industry leader in natural androgen supplements for men. Since 2006 our mission has been clear -- maximize the male hormone environment without compromising health. Our products are backed by thousands of positive reviews, success stories, and detailed case reports.
We take responsibility for our customers and take pride in the following -
***8226; Most Trusted - Established industry leader since 2006 with an ***8220;A***8221; reliability rating by the BBB
***8226; Exceptional Quality - 100% purity & identity testing
***8226; Knowledgeable Staff - Hormone specialists available from 9-5pm PST (Email/Chat)
***8226; Industry Innovator - Nearly 100% of profits are reinvested into future R&D
Order Now = Get Started Tomorrow
It can be difficult or nearly impossible to make progress to your physique with low androgen levels. If you are tired of being stuck in a plateau, take action now -- and give your body what it needs to take your progress to the next level.
Remember, AndroLean gives you -
***8226; Proven Safety - Extensive in-house blood data confirms exceptional safety profile (65)
***8226; Proven Effectiveness - Average 3lb lean mass, and 3% reduction in body fat in only 8 weeks
***8226; Proven Natural & Legal - Non-toxic naturally occurring androgens are found in the food supply
If quality, safety, and effectiveness are important to you -- AndroLean is your #1 choice.
Head over to primordialperformance.com and order AndroLean now
Thank you for your support.
Eric Potratz
Primordial Founder & President
Questions?
Phone ***8211; 1-503-841-6702
Email - info@primordialperformance.com
9am-11pm PST Live Chat - Primordial Performance Live Support
Visit - primordialperformance.com
Primordial Performance LLC
13331 NE Whitaker Way
Portland OR 97230
References ***8211;
1. Androgens and anabolic agents
Julius A. Vida
Chemistry and pharmacology (1969)
2. THE ASSAY OF SUBCUTANEOUSLY INJECTED ANDROGENS IN THE CASTRATED RAT
Ralph I. Dorfman, et al.
Acta Endocrinol February 1, 1963 42 245-253
3. ÉTUDE COMPARATIVE DES EFFETS SEXUELS DES ANDROGÉNES NATURELS
C.J. Meyer, et al.
Acta Endocrinol May 1, 1963 43 27-46
4. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH, et al.
Minerva Endocrinol. 2007 Sep;32(3):141-59.
5. The native anti-glucocorticoid paradigm.
Muller C, et al.
J Steroid Biochem Mol Biol. 2006 Jul;100(1-3):95-105. Epub 2006 May 18.
6. Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue.
Samra JS, et al.
J Clin Endocrinol Metab. 1998 Feb;83(2):626-31.
7. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
Seckl JR, et al.
Recent Prog Horm Res. 2004;59:359-93.
8. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
Tomlinson JW, et al.
J Clin Endocrinol Metab. 2007 Mar;92(3):857-64. Epub 2007 Jan 2.
9. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ, et al.
J Steroid Biochem Mol Biol. 2007 May;104(3-5):161-8. Epub 2007 Mar 23.
10 Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.
Gravholt CH, et al.
Obes Res. 2002 Aug;10(8):774-81.
11. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans.
Djurhuus CB, et al.
Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E172-7.
12. Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue.
Simonyte K, et al.
J Clin Endocrinol Metab. 2010 Jul;95(7):3527-31. Epub 2010 Apr 21.
13. Breaking the vicious circle of obesity: the metabolic syndrome and low testosterone by administration of testosterone to a young man with morbid obesity.
Tishova Y, et al.
Arq Bras Endocrinol Metabol. 2009 Nov;53(8):1047-51.
14. Steroids and thermogenesis.
Hampl R, et al.
Physiol Res. 2006;55(2):123-31. Epub 2005 May 24.
15. Definition of androgens and protein anabolic steroids.
Kochakian CD.
Pharmacol Ther B. 1975;1(2):149-77. Review. No abstract available.
16. Androgens and erythropoiesis: past and present.
Shahani S, et al.
J Endocrinol Invest. 2009 Sep;32(8):704-16. Epub 2009 Apr 7. Review.
17. Breaking the vicious circle of obesity: the metabolic syndrome and low testosterone by administration of testosterone to a young man with morbid obesity.
Tishova Y, et al.
Arq Bras Endocrinol Metabol. 2009 Nov;53(8):1047-51.
18. A randomized, double blind, placebo controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweight adults.
Kalman et al.
Curr Ther Res; 2000;67(7):435-442
19. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H, et al.
Curr Drug Targets Immune Endocr Metabol Disord. 2003 Dec;3(4):255-62.
20. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
Latif SA, et al.
Mol Cell Endocrinol. 2005 Nov 24;243(1-2):43-50. Epub 2005 Sep 26.
21. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR.
Proc Nutr Soc. 2007 Feb;66(1):1-8.
22. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents.
Boyle CD, et al.
Expert Opin Ther Pat. 2009 Jun;19(6):801-25.
23. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Morgan SA, et al.
Diabetes. 2009 Nov;58(11):2506-15. Epub 2009 Aug 12.
24. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA).
Kalimi M, et al.
Mol Cell Biochem. 1994 Feb 23;131(2):99-104.
25. Relationship of dehydroepiandrosterone and cortisol in disease.
Hechter O, et al.
Med Hypotheses. 1997 Jul;49(1):85-91.
26-38. Ignore
39. Testosterone dose-response relationships in healthy young men.
Bhasin S, et al.
Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1172-81.
40. Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men.
Woodhouse LJ, et al.
J Clin Endocrinol Metab. 2004 Feb;89(2):718-26.
41. Testosterone Threshold Levels and Lean Tissue Mass Targets Needed to Enhance Skeletal Muscle Strength and Function: The HORMA Trial.
Sattler, F et al.
J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):122-9.
42. Conversion of androsterone ester to dihydrotestosterone (DHT) -- with 10 hour pharmacokinetics
Draws performed by AnyLabTestNow, 714 SW Washington St, Portland, OR 97205 , July 2011.
Analysis performed by S.E.D. Medical Laboratories.
(Contact Primordial Performance for full report)
43. In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man.
Horton R, et al.
J Clin Endocrinol Metab. 1967 Jan;27(1):79-88.
44. In vitro metabolism of androgens in whole human blood.
Blaquier et al.
Acta Endocrinol (Copenh). 1967 Aug;55(4):697-704. No abstract available.
45. METABOLISM OF ANDROST-4-ENE-3,17-DIONE-4-14C BY RABBIT SKELETAL MUSCLE SUPERNATANT FRACTION. ISOLATION OF 3BETA-HYDROXYANDROST-4-EN-17-ONE-14C AND TESTOSTERONE-14C.
THOMAS et al.
J Biol Chem. 1964 Mar;239:766-72. No abstract available
46. Direct agonist/antagonist functions of dehydroepiandrosterone.
Chen et al.
Endocrinology. 2005 Nov; 146(11):4568-76. Epub 2005 Jun 30
47. Serum androgen bioactivity during 5alpha-dihydrotestosterone treatment in elderly men.
Raivio et al.
J Androl. 2002 Nov-Dec;23(6):919-21.
48. In vitro bioassays for androgens and their diagnostic applications.
Roy et al.
Hum Reprod Update. 2008 Jan-Feb;14(1):73-82. Epub 2007 Dec 4.
49. Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay.
Roy et al.
J Steroid Biochem Mol Biol. 2006 Sep; 101(1):68-77. Epub 2006 Aug 8.
50. Circulating bioactive androgens in midlife women.
Chen et al.
J Clin Endocrinol Metab. 2006 Nov;91(11):4387-94. Epub 2006 Aug 29.
51. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
Chen Fet al.
J Steroid Biochem Mol Biol. 2004 Aug;91(4-5):247-57.
52. Delta-4-androstene-3,17-dione binds androgen receptor, promotes myogenesis in vitro, and increases serum testosterone levels, fat-free mass, and muscle strength in hypogonadal men.
Jasuja R, et al.
J Clin Endocrinol Metab. 2005 Feb;90(2):855-63. Epub 2004 Nov 2.
53. In vivo MRI evaluation of anabolic steroid precursor growth effects in a guinea pig model.
Tang H, et al
Steroids. 2009 Aug;74(8):684-93. Epub 2009 Mar 20.
54. Strength Training and Anabolic Steroids
Anders Eriksson, et al.
University Medical Dissertations (2006)
55. Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining.
Bruusgaard JC. et al.
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15111-6. Epub 2010 Aug 16.
56. Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin.
Gentile, M.A. et al.
J. Mol. Endocrinol. 44, 55***8211;73 (2010)
57. Effects of anabolic steroids on the muscle cells of strength-trained athletes.
Kadi F, et al.
Med Sci Sports Exerc 31:1528***8211;1534. (1999)
58. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy.
Sinha-Hikim I, et al.
Am J Physiol Endocrinol Metab 283:E154***8211;E164 (2002)
59. Stimulation of both estrogen and androgen receptors maintains skeletal muscle mass in gonadectomized male mice but mainly via different pathways.
Svensson J, et al.
J Mol Endocrinol. 2010 Jul;45(1):45-57. Epub 2010 Apr 30.
60. The male climacterium: clinical signs and symptoms of a changing endocrine environment.
van den Beld AW, et al.
Prostate Suppl. 2000;10:2-8.
61. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample.
Hall SA, et al.
J Clin Endocrinol Metab. 2008 Oct;93(10):3870-7. Epub 2008 Jul 29.
62. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.
Wu FC, et al.
J Clin Endocrinol Metab. 2008 Jul;93(7):2737-45. Epub 2008 Feb 12.
63. Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin Suppression
Andrea D. Coviello, et al
J. Clin. Endocrinol. Metab., May 2005; 90: 2595 ***8211; 2602.
64. Effect of long term deprivation of luteinizing hormone on Leydig cell volume, Leydig cell number, and steroidogenic capacity of the rat testis.
Keeney DS, et al.
Endocrinology 1988; 123:2906-2915.
65. Based on comparison to "natural androgen" based supplements, including 4-DHEA, 1-DHEA, 11-DHEA, androsterone, and epiandrosterone products.
Last edited:
